EIR Sovereign Pharmaceuticals Jun 2013

Lucas Leake FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observation (via FDA 483) on 21 Jun 2013.

Product details

  • Category:
  • Inspection end: 21 Jun 2013
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart